Roy, P.; Banik, D.; Chowdhury, F.; Bakar Siddique, M. A. Magnitude of Survival Benefit Associated With Tyrosine Kinase Inhibitors in Advanced Thyroid Carcinoma: A Systematic Review and Meta-Analysis Incorporating Updated Long-Term Evidence From SELECT (Lenvatinib) and COSMIC-311 (Cabozantinib) Trials. World J Oncol 2026, 17 (5), 599-613. https://doi.org/10.14740/wjon2842.